1022983-26-1

Upstream product

• 6959-47-3 2-chloromethylpyridine hydrochloride 
• 129422-96-4 1-(p-toluenesulfonyl)-1,4,7-triazacyclononane 

Relevant academic research and scientific papers

Photo- and electrocatalytic H2 production by new first-row transition-metal complexes based on an aminopyridine pentadentate ligand

The synthesis and characterisation of the pentadentate ligand 1,4-di(picolyl)-7-(p-toluenesulfonyl)-1,4,7-triazacyclononane (Py 2Tstacn) and their metal complexes of general formula [M(CF3SO3)(Py2sup

Significant relaxivity gap between a low-spin and a high-spin iron(II) complex of structural similarity: An attractive off-on system for the potential design of responsive MRI probes

We have identified a pair of structurally similar iron complexes in the oxidation state ii that exist in a low-spin and a high-spin electronic spin state in aqueous media, respectively. The low-spin, diamagnetic complex (LS, 1) is mute in MRI while the high-spin, paramagnetic complex (HS, 2) generates considerable contrast in MRI. These results demonstrate that iron(ii) complexes, hitherto neglected for contrast enhancement in MRI, have potential for the design of an MRI probe that suffers passage from one state to the other under the influence of a targeted biochemical activity and thus operates in an off-on mode. At 300 MHz (proton resonance frequency at 7 T field strength) and in phosphate buffer, we found a longitudinal relaxivity (r1) of 1.29 mM -1 s-1 for 2 that, in light of the difference in unpaired electrons of the central metal atoms (4 for FeII; 7 for Gd III), comes remarkably close to that of gadolinium(iii)-DOTA (2.44 mM-1 s-1), a commercialized MRI contrast agent. Since gadolinium complexes are always paramagnetic and can therefore not be muted in MRI, the here presented Fe(ii)-based system offers an alternative strategy to develop responsive MRI probes. The Royal Society of Chemistry and the Centre National de la Recherche Scientifique.

Contrast Agents for Magnetic Resonance Imaging

The invention relates to contrast agents for magnetic resonance imaging comprising a chelating ligand and a transition metal ion, said ligand carrying a substituent capable of reacting chemically or biochemically with a target substance while bringing about a change in the spin state.